SAN RAFAEL, Calif.--(BUSINESS WIRE)--Eastbourne Capital Management, L.L.C. today announced that independent proxy voting advisory firm Egan Jones Proxy Services has recommended that shareholders of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) vote on Eastbourne’s WHITE proxy card and support change to the 12 member Board of Directors at Amylin’s 2009 Annual Meeting of Shareholders. Egan Jones’ recommendation follows recommendations recently issued by RiskMetrics Group, Glass Lewis & Co and PROXY Governance, all supporting the election of Eastbourne and Icahn nominees. In its report, Egan Jones has recommended Amylin shareholders vote Eastbourne’s WHITE proxy card FOR the election of Eastbourne nominees, Dr. Kathleen Behrens and Jay Sherwood, along with Icahn nominee, Dr. Alex Denner.
